Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia

BACKGROUND: Vulval intraepithelial neoplasia (VIN) is a premalignant condition, which is frequently associated with type HPV16 infection, and multifocal disease has high rates of surgical treatment failure. METHODS: We report a phase II clinical trial of the topical immunomodulator, imiquimod, for 8...

Descripción completa

Detalles Bibliográficos
Autores principales: Daayana, S, Elkord, E, Winters, U, Pawlita, M, Roden, R, Stern, P L, Kitchener, H C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853099/
https://www.ncbi.nlm.nih.gov/pubmed/20234368
http://dx.doi.org/10.1038/sj.bjc.6605611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853099/
https://www.ncbi.nlm.nih.gov/pubmed/20234368
http://dx.doi.org/10.1038/sj.bjc.6605611

Ejemplares similares